GSK3B and neoplasm: 9-ING-41 is also a potent, selective small molecule inhibitor of GSK-3β, which has demonstrated anti-tumor activity in patient-derived xenograft mice (PDX) of various human cancers including PDAC [49,55,56,57,58,59].